Cigna unit accused of ignoring federal, state drug pricing benchmarks for workers' compensation beneficiaries Massachusetts previously settled with UnitedHealth's OptumRx, pharmacies (Reuters) - ...

Express Scripts, one of the largest pharmacy benefit managers in the country, overcharged U.S. Postal Service employees by a whopping $45 million for their prescription drugs during a recent five-year ...

Express Scripts is suing the Federal Trade Commission (FTC), demanding the retraction of a report it claims is false and harmful to the pharmacy benefit manager (PBM) industry. Express Scripts is ...

A pharmacy technician pulls medication from storage in the Exchange Pharmacy at Davis-Monthan Air Force Base, Ariz., May 23, 2023. (U.S. Air Force photo by Staff Sgt. Abbey Rieves) Two dozen Democrat ...

The FTC accuses major PBMs of inflating insulin prices, impacting patient costs and access to affordable medications. PBMs prioritize high-rebate drugs, contributing to high insulin prices and ...

Guarantee installed power, lighting, UPS back-up power, emergency, fire alarm, data and security system raceways. The center, which has the capacity to dispense, package and ship more than 110,000 ...

Healthcare consolidation took another major step Thursday with Cigna's move to scoop up the last large independent pharmacy benefits manager Express Scripts in a $54 billion deal. And that could spell ...

Cigna Corp. and Express Scripts said they closed their merger on Thursday, less than a year after the companies first agreed to combine in a deal that further transforms the healthcare landscape.

Two of the largest pharmacy benefit managers in the United States are suing the Arkansas Board of Pharmacy to stop a new law that prohibits the drug middlemen from owning pharmacies in the state, ...

Health insurance giant Cigna is buying Express Scripts, the company that administers prescription drug insurance plans for millions of Americans, in a deal worth $67 billion, including $15 billion in ...

When Express Scripts unveils its national preferred formulary each year, industry watchers immediately look to its decisions for clues about trends in the drug business. It’s no different this year, ...